Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia

Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may in...

Full description

Bibliographic Details
Main Authors: Yu Seob Shin, Keshab Kumar Karna, Bo Ram Choi, Jong Kwan Park
Format: Article
Language:English
Published: Korean Society for Sexual Medicine and Andrology 2019-05-01
Series:The World Journal of Men's Health
Subjects:
_version_ 1811344987341717504
author Yu Seob Shin
Keshab Kumar Karna
Bo Ram Choi
Jong Kwan Park
author_facet Yu Seob Shin
Keshab Kumar Karna
Bo Ram Choi
Jong Kwan Park
author_sort Yu Seob Shin
collection DOAJ
description Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may independently increase the risk of erectile dysfunction (ED). However, many investigators believe that side effects of 5α-RIs will disappear with continuous treatment. Considerable controversy exists regarding the severity and persistence of side effects of finasteride on ED. The aim of this review was to summarize current research studies on finasteride associated with ED. The search strategy used each term of finasteride and ED against PubMed database to identify related studies. ED data reported from available trials for finasteride were summarized and reviewed. Although there is not enough evidence to prove the relationship between finasteride and ED, most studies in this review found that finasteride for BPH was correlated with ED. However, most studies included in this review revealed that finasteride for MAA was not correlated with ED. On the other hand, some studies reported side effects of finasteride associ-ated with sexual dysfunction, including ED, male infertility, ejaculation problem, and loss of libido, even in MAA patients. Well-designed randomized controlled trials are needed to further determine the mechanism and effects of finasteride on ED. However, physicians should discuss with their patients possible long-term effects of finasteride on sexual function, although we do not have evidence showing that adverse events of sexual dysfunction are absolutely associated with 5α-RIs.
first_indexed 2024-04-13T19:56:20Z
format Article
id doaj.art-527e74f7b2154d0ca5350daf270bc6fa
institution Directory Open Access Journal
issn 2287-4208
2287-4690
language English
last_indexed 2024-04-13T19:56:20Z
publishDate 2019-05-01
publisher Korean Society for Sexual Medicine and Andrology
record_format Article
series The World Journal of Men's Health
spelling doaj.art-527e74f7b2154d0ca5350daf270bc6fa2022-12-22T02:32:20ZengKorean Society for Sexual Medicine and AndrologyThe World Journal of Men's Health2287-42082287-46902019-05-0137215716510.5534/wjmh.180029Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic AlopeciaYu Seob Shin0Keshab Kumar Karna1Bo Ram Choi2Jong Kwan Park3Department of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaDepartment of Urology, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute and Clinical Trial Center of Medical Device of Chonbuk National University Hospital, Jeonju, KoreaFinasteride is primarily used to treat benign prostatic hyperplasia (BPH) and male androgenetic alopecia (MAA). Five-alpha reductase inhibitors (5α-RIs) could induce male sexual dysfunction due to their effects on testosterone and dihydrotestos-terone. There is evidence suggesting that 5α-RIs may independently increase the risk of erectile dysfunction (ED). However, many investigators believe that side effects of 5α-RIs will disappear with continuous treatment. Considerable controversy exists regarding the severity and persistence of side effects of finasteride on ED. The aim of this review was to summarize current research studies on finasteride associated with ED. The search strategy used each term of finasteride and ED against PubMed database to identify related studies. ED data reported from available trials for finasteride were summarized and reviewed. Although there is not enough evidence to prove the relationship between finasteride and ED, most studies in this review found that finasteride for BPH was correlated with ED. However, most studies included in this review revealed that finasteride for MAA was not correlated with ED. On the other hand, some studies reported side effects of finasteride associ-ated with sexual dysfunction, including ED, male infertility, ejaculation problem, and loss of libido, even in MAA patients. Well-designed randomized controlled trials are needed to further determine the mechanism and effects of finasteride on ED. However, physicians should discuss with their patients possible long-term effects of finasteride on sexual function, although we do not have evidence showing that adverse events of sexual dysfunction are absolutely associated with 5α-RIs.AlopeciaErectile dysfunctionFinasterideProstatic hyperplasia
spellingShingle Yu Seob Shin
Keshab Kumar Karna
Bo Ram Choi
Jong Kwan Park
Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
The World Journal of Men's Health
Alopecia
Erectile dysfunction
Finasteride
Prostatic hyperplasia
title Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
title_full Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
title_fullStr Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
title_full_unstemmed Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
title_short Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
title_sort finasteride and erectile dysfunction in patients with benign prostatic hyperplasia or male androgenetic alopecia
topic Alopecia
Erectile dysfunction
Finasteride
Prostatic hyperplasia
work_keys_str_mv AT yuseobshin finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia
AT keshabkumarkarna finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia
AT boramchoi finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia
AT jongkwanpark finasterideanderectiledysfunctioninpatientswithbenignprostatichyperplasiaormaleandrogeneticalopecia